SL NAME TITLE OF ASSIGNMENT REMARKS

N
O
1 AARUSHI KUKRETI  Role of SUPAC Guidelines in Streamlining Generic Drug Manufacturing in 2025

2 AKANKSHA BISWAS  Impact of Quality by Design (QbD) on Modern Pharmaceutical Development

3 ALFIYA MUSTAFA  Challenges in Scaling Up Liquid Oral Formulations for Global Markets

4 ANJANA SINGH  Technology Transfer Protocols for mRNA Vaccine Production

5 AYUSHI TYAGI  Regulatory Challenges in Approving Biosimilars in India

6 DIKSHA SHAH  Importance of Confidentiality Agreements in Technology Transfer

7 ISHA KAPOOR  Application of Six Sigma in Reducing Pharmaceutical Manufacturing Errors

8 KAVITA KUMARI  Space Requirements for Pilot Plants in Biologics Production

9 KOMAL TIWARI  WHO Guidelines for Technology Transfer in Low-Resource Settings

10 KUMARI SARITA  Role of CDSCO in Regulating New Drug Approvals in India

11 MANSI JAKHMOLA  Quality Risk Management in Pharmaceutical Technology Transfer

12 MEENAKSHI NEGI  Impact of ISO 9000 Standards on Pharmaceutical Quality Systems

13 MONIKA  Challenges in Analytical Method Transfer for Generic Drugs

14 MUSKAN SINGH  Significance of Investigator’s Brochure in Clinical Trials

15 NANDITA KUMARI  Scaling Up Solid Dosage Forms: Current Industry Trends

16 NISHA KUMARI  Role of NRDC in Facilitating Technology Transfer in India

17 PREETI RAWAT
 Regulatory Requirements for mRNA-Based Therapeutics in 2025
 Application of Platform Technology in Vaccine Development
18 PREMA RANA  Importance of GLP in Ensuring Pharmaceutical Product Safety

19 TANUJA KARAKOTI  Challenges in Commercializing Biologics: Case Study Analysis

20 VANDANA BHARTI  Role of Biostatistics in Clinical Trial Data Analysis

21 ABHISHEK KUMAR  Impact of ISO 14000 on Sustainable Pharmaceutical Manufacturing

22 ABHISHEK RAI  Technology Transfer from R&D to Production: Case Studies

23 ACHIT KUMAR KANNOJIYA  Regulatory Affairs in Navigating Global Drug Approval Processes

24 ADITYA PRAKASH SINGH  Pilot Plant Considerations for Semi-Solid Formulations

25 AKASH MAURYA  Role of TIFAC in Supporting Pharma Innovation in India

26 AMIT KUMAR MAHATO  Managing Out of Specifications (OOS) in Drug Manufacturing

27 AMIT KUSHWAHA  Validation Challenges in Pharmaceutical Equipment Scale-Up

28 AMIT MEENA  Importance of MoUs in Technology Transfer Agreements

29 ASHUTOSH SINGH  Role of BCIL in Promoting Biotech Technology Transfer

30 ATUL KUMAR RAMAN  Regulatory Strategies for Expedited Drug Approvals in Emergencies

31 AYUSH RAJ  Impact of Change Control on Pharmaceutical Quality Systems

32 BITTU  Pilot Plant Raw Material Challenges in Biosimilar Production

34 HARISH MEENA  Technology Transfer for API Production: Current Challenges

35 KAMAL PANDEY  Significance of NABL Accreditation in Quality Testing Labs

36 LIYAKAT ALI  Clinical Research Protocols for Rare Disease Treatments

37 LOKESH KUMAR  Scaling Up Biopharmaceuticals: Personnel Training Needs

39 MANISH MANIKPURI  Quality Control in Technology Transfer for Packaging Materials

40 OM JEET  Regulatory Requirements for Non-Clinical Drug Development

42 PAPPU YADAV  Challenges in Data Presentation for FDA Submissions

43 PREET ANAND  Legal Issues in Pharmaceutical Technology Transfer

44 PRIYANSHU KUMAR MAHUR  Role of APCTD in Facilitating Technology Transfer in India

45 ROHIT KUMAR  Pilot Plant Documentation for Regulatory Compliance

46 RUDRAKSH  Application of Quality by Design in Continuous Manufacturing

47 SATYAM KUMAR  Role of State Licensing Authorities in Drug Regulation

48 SHIVAM GUPTA  Technology Transfer for Excipients: Industry Best Practices

49 SHUBHAM KUMAR  Managing Clinical Studies for New Drug Applications

50 SOHAM SADHUKHAN  Importance of Certificate of Pharmaceutical Product (COPP)

51 SUMIT KUMAR  Challenges in Scaling Up Topical Semi-Solid Formulations

52 TANISH BHARDWAJ  Role of Pharmacology in Non-Clinical Drug Development

53 VIDHANSHU PAINULY  Impact of Regulatory Authorities on Global Pharma Markets

54 VIJAY BHANDARI  Technology Transfer for Finished Pharmaceutical Products

55 VIVEK KUMAR YADAV  Six Sigma Applications in Reducing Batch Failures

56 ANUSHKA RAWAT  Historical Evolution of Regulatory Affairs in Pharma

58 KHUSHBU KUMARI RAI  Role of Drug Metabolism Studies in New Drug Development

59  Challenges in Qualifying Pilot Plant Equipment

60 ADARSH SHARMA  Regulatory Requirements for Conducting BE Studies in India

61 AJAY KUMAR  Impact of Quality Management Systems on Drug Recalls

62 CHANDRA BHAN SONKAR  Technology Transfer Documentation: Best Practices in 2025

63 CHETAN CHAMKANI  Role of TBSE in Supporting Pharma Startups in India

64 PRAVESH NEGI  Challenges in Managing Clinical Research Data

65 PRASHANT KUMAR Importance of ISO Standards in Pharmaceutical Quality Control

68

69

70